NCT04963517 2024-12-06
proGAIT
Universität Duisburg-Essen
Phase 2/3 Completed
Clinical Trials
5 trialsNCT05057130 2024-04-01
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
Blokhin's Russian Cancer Research Center
Phase 2/3 Recruiting
NCT02302651 2014-11-27
Non-invasive Focal Therapy for Osteoid Osteoma
University of Roma La Sapienza
Phase 2/3 Unknown
NCT00851162 2012-11-28
Using Mesenchymal Stem Cells to Fill Bone Void Defects in Patients With Benign Bone Lesions
Emory University
Phase 2/3 Withdrawn
NCT00127387 2012-06-26
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
The University of Texas Health Science Center at San Antonio
Phase 2/3 Terminated